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ABSTRACT
The ability to rapidly and efficiently generate reli-
able Cre/loxP conditional transgenic mice would
greatly complement global high-throughput gene
targeting initiatives aimed at identifying gene func-
tion in the mouse. We report here the generation of
Cre/loxP conditional ROSA26-targeted ES cells
within 3–4 weeks by using Gateway cloning to
build the target vectors. The cDNA of the gene of
interest can be expressed either directly by the
ROSA26 promoter providing a moderate level of
expression or by a CAGG promoter placed in
the ROSA26 locus providing higher transgene
expression. Utilization of F1 hybrid ES cells with
exceptional developmental potential allows the
production of germ line transmitting, fully or
highly ES cell-derived mice by aggregation of
cells with diploid embryos. The presented stream-
lined procedures accelerate the examination of
phenotypical consequences of transgene expres-
sion. It also provides a unique tool for comparing
the biological activity of polymorphic or splice var-
iants of a gene, or products of different genes
functioning in the same or parallel pathways in an
overlapping manner.
INTRODUCTION
Mouse embryonic stem (ES) cells (1,2) have revolutionized
the genetic approaches taken in addressing the biolog-
ical function of mammalian genes. Many have been
inactivated or Cre recombinase conditionally mutated by
gene targeting. Complementing these loss-of-function
approaches many gain-of-function transgenic mouse
models have previously been developed by random inser-
tion transgenesis in ES cells or after pronuclear microin-
jection (3–6). The main limitation associated with random
insertion transgenic approaches is the unpredictable
variegation of transgene expression (7,8) due to the
eﬀect of genomic integration site or transgene copy
number (9).
Transgene insertion into the ROSA26 locus (10,11) by
targeting has emerged as a favoured solution to gain better
control on gene expression. This site provides high target-
ing eﬃciency and ubiquitous transgene expression at mod-
erate levels (10,11). The drawback of this approach was
the increased complexity of target vector building. More
recently, however, several in vitro recombinase-based
systems have been developed that have greatly decreased
the diﬃculty of vector construction. The Gateway DNA
cloning technology (12,13) has become popular for clon-
ing DNA elements into plasmids with very high eﬃciency
(90–100%). It consists in the transfer of any sequence
(i.e. cDNA) ﬂanked by speciﬁc lambda phage integrase
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corresponding heterotypic (attR) sites via in vitro recom-
bination (LR reactions). In addition, the base pairs at the
core of the att recombination site determine their recom-
bination speciﬁcity, and mutations within these core
sequences have created unique recombination speciﬁcity
allowing multiple elements to be recombined in tandem
(hence the name MultiSite Gateway). This system has
been applied in powerful and innovative ways to recom-
bine promoter-based elements with ORF, drug-selectable
cassettes and/or reporter markers (14,15).
We present here the eﬃcient generation of Cre/loxP
conditional ROSA26 targeting vectors utilizing the ease
of Gateway technology. These targeting vectors were
used to create several allelic series in the ROSA26 locus
of F1 hybrid mouse ES cells. The exceptional developmen-
tal potential of these lines allowed the production of germ-
line transmitting chimeras in an extremely eﬃcient, rapid
and cost-eﬀective manner by simple aggregation with
eight-cell stage embryos. The advancements achieved by
combining these tools will signiﬁcantly reduce the time
and costs associated with functional analysis in the mouse.
METHODS AND MATERIALS
Gateway-compatible pEntry andpDestination vector
construction
Destination vectors. The Gateway-compatible pROSA26
Destination Vector (pROSA26-DV1 LMBP 6350) was
generated by sub-cloning the attR1-ccdB-chloramphenicol
resistance gene (CmR)-attR2 fragment (EcoRV) into a
blunt-ended XhoI site of the modiﬁed pBigT vector (11)
downstream of the SA(splice acceptor)-loxP-PGK-neo-
3xpA-loxP cassette and upstream of an IRES-eGFP-
pA+ cassette [the IRES-eGFP cassette was previously
cloned from the pCALL2-IRES-eGFP vector (a gift
from Dr. Corrine Lobe) as a XhoI–NotI fragment into
the pBigT vector]. This plasmid was subsequently digested
with the unique cutters AscI/PacI and cloned into the
pROSA26 targeting vector (AscI/PacI) as previously
described (10). The MultiSite pROSA26 Destination
Vectors (pROSA26-DV3 LMBP 6352 and pROSA26-
DV2 LMBP 6351) were made by blunt-end cloning the
R4-ccdB-CmR-R3 fragment from a pBigT-R4-ccdB-
CmR-R3 plasmid intermediate into the pROSA26 vector
that was cut with PacI and blunt-ended. Orientation rela-
tive to the 50 targeting arm was determined by restriction
enzyme analysis and DNA sequencing.
pEntry vectors. The attL1-attL2 ﬂanked cDNA pEntry
constructs used in combination with the pROSA26
Destination Vectors were generated as described in
Supplementary Figure 1 legend. The 50 pEntry attL4-
pCAGG-loxP-bgeo-3xpA-loxP-attR1 vector (LMBP
6354) was constructed by cloning the pCAGG-loxP-
bgeo-3xpA+ fragment (ScaI/XhoI) from the pCall2-
IRES-eGFP vector into the pEntry L4-R1 vector
(BamHI-Blunt ended XhoI). The 30 pEntry attR2-IRES-
eGFP-attL3 vector (LMBP 6353) was constructed by
cloning the IRES-eGFP fragment (XhoI/NotI-blunt)
from pcCALL2-IRES-eGFP into pEntry R2L3 (SalI/
XhoI-blunt). The plasmids that have been assigned an
LMBP accession number are available from the BCCM/
LMBP Plasmid collection, Department of Biomedical
Molecular Biology, Ghent University, Belgium (http://
bccm.belspo.be/about/lmbp.php <http://bccm.belspo.be/
about/lmbp.htm>; bccm.lmbp@dmbr.ugent.be).
BP and LR reactions. BP and LR reactions were per-
formed using Clonase
TM Enzyme Mix (Invitrogen)
according to the suppliers’ instructions with some modiﬁ-
cations. Brieﬂy for the monosite Gateway LR reactions
100ng of the pEntry clone and 150ng pROSA26-DV
in the LR Clonase II mix were left ON at RT. For the
MultiSite LR reactions, 100ng of each of the 3 pENTRY
vectors were ﬁrst incubated with the LR Clonase II mix
for 7–8h at RT and 150ng of the appropriate pROSA26
Destination vector was added with additional Clonase II
mix ON at RT.
Bacterial host and transformation. For construction of
destination vectors containing the ccdB gene, library eﬃ-
ciency DB3.1
TM electro-competent cells (Invitrogen) were
used. For the expression clones DH5 alpha
TM (Invitrogen)
electro-competent cells were used. For bacterial transfor-
mation protocols refer to Supplementary Figure 1 legend.
Sequencing and primers. All plasmid sequencing was con-
ducted at the VIB sequencing facility (ABI3730XL,
Applied Biosystems). In order to conﬁrm correct sequence
of the inserts of pROSA26 derived expression clones
the following primers were used. For the monosite
pROSA26-DV1-derived expression clones the sequencing
primers S1for (ATCATGTCTGGATCCCCATC) S2rev
(GGGGCGGAATTCGATATCAAG) were used (see
Figure 1A). For monitoring the degree of excision from
tissue samples obtained from the non-excised and excised
ROSA26-pCAGG-MDM4 mice the G3for (TCGCTACC
ATTACCAGTTGGT) and G4rev (CTCTGCTAACCAT
GTTCATGC) and G5for (GTAGGCAGTGTGTGAGT
ATC) primers were used.
PCR and Southern analysis
PCR-based screening of targeted ROSA26 ES cell clones
was performed using the external G1for primer (TAGGT
AGGGGATCGGGACTCT) and the internal G2rev
primer (GCGAAGAGTTTGTCCTCAACC) to generate
a 1.3-kb PCR fragment (Supplementary Figure 1A). PCR
positive clones were conﬁrmed by Southern blotting for
50 integration using the 50 external probe (550bp) and
BamH1 digests of genomic DNA (5.8-kb wt allele and
3.0kb targeted allele). 30 integration was conﬁrmed using
the 30 external probe (800bp) and Kpn1 digests (37-kb wt
allele and 8.8-kb targeted allele). Both the 50 and 30 exter-
nal Southern probes were generated and provided as a
generous gift by Michael Taschner and Dr. Christine
Hartmann (IMP, Vienna). An internal Neo probe was
used with EcoRV digests to detect a single 4.0-kb
ROSA26-targeted allele. For the MultiSite pCAGG pro-
moter targeting experiments to the ROSA26 locus in the
sense/anti-sense orientation double EcoRI/KpnI digests
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ment lengths of 5kb and 6kb for targeted events for the
anti-sense and sense orientation respectively and an 11-kb
fragment for the non-targeted wild-type allele. Similarly,
the 30 external probe generated an 8.8-kb and 9-kb frag-
ment for the anti-sense and sense orientation respectively
for the targeted allele and an 11-kb fragment for the wild-
type allele. An internal eGFP probe was used to generate a
single 5-kb and 6-kb fragment for the anti-sense and
sense orientation respectively indicative of single-copy
integration.
ES cell cultureand aggregations
ES cell culture. The G4 ES cell line was grown and
manipulated as previously described (16). Brieﬂy, the G4
ES cells were always grown and manipulated at 378Ci n
5% CO2 on mitomycin C-treated mouse embryonic ﬁbro-
blasts [derived from TgN (DR4)1 Jae embryos] in high-
glucose DMEM (Invitrogen), supplemented with 15% ES
cell-grade FBS (HyClone), 0.1mM 2-mercaptophenol,
2mM L-glutamine, 1mM sodium pyruvate, 0.1mM
non-essential amino acids and 2000U/ml recombinant
LIF (DMBR/VIB Protein Service facility). Further expan-
sion and manipulation of these ES cell clones is summa-
rized in Supplementary Figure 1 legend. Parental ES cells
were electroporated with the pCAGG-NLS-Cre, PGK-
puro plasmid (gift from Dr. Corinne Lobe) and selected
according to the protocol outlined in Supplementary
Figure 1 legend.
Aggregations. Chimaeras were generated by aggregation
of ROSA26-targeted ES cells with CD1 and/or Swiss
eight-cell stage embryos as described previously (17).
The entire procedure is summarized in Supplementary
Figure 1 legend.
RNA extraction and quantitative (q)RT-PCR
Total RNA was extracted from ES cells or polytron-
homogenized tissues with TRIZOL (Invitrogen) and pur-
iﬁed using phenol/chloroform or RNeasy mini columns
(Qiagen). DNaseI treatment was performed at 378C for
30min, followed by cDNA synthesis (Superscript II
RNase H reverse transcriptase, Invitrogen) starting from
equal amounts of RNA. Q-RT-PCR was performed on a
LightCycler 480 system (Roche) using SYBR Green I or
Probe Master kit (Roche). Gene expression was normal-
ized for at least two of the following reference
genes: hypoxanthine-guanine phosphoribosyltransferase
(HPRT), b-actin, glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) and hydroxymethylbilane synthase
(HMBS), and results were considered valid only when
consistent with multiple internal controls. The primers
and probes used for Snai1, Snai2, MDM4, eGFP were
as follows: Snai1for: CAGGACTCTAATCCAGAGTTT
ACCTTC, rev: GGGATGGCTGCCAGCA, probe: AGC
AGCCCTACGACCAGGCCCA; Snai2for: GCCAAAC
TACAGCGAACTGGA, rev: TGTGGTATGACAGGC
ATGGAG; probe: CACATACAGTGATTATTTCCCC
GTATCTCTA GFPFor: TGTCGCCCTCGAACTTCA
C; rev: GAGCGCACCATCTTCTTCAAG; GFP-probe
ACGACGGCAACTAC; MYC-Mdm4for: AGAAGTT
GATCTCCGAGGAGGAT, MYC-Mdm4rev: GCTGTC
AGATGCGGAACACT, MYC-Mdm4-probe: CCATTC
CACCTCCGCCC.
b-Galactosidase staining, immunohistochemistry and
western analysis
The X-gal staining of ES cells and embryos was performed
ON at RT as described previously (18). For the E14.5day
embryos staining, they were ﬁst cut sagitally with a razor
blade to allow penetration of the X-gal staining reagents.
For small pieces of adult tissues, the sections were ﬁrst
whole-mount X-gal stained ON and post-ﬁxed in 4% par-
aformaldehyde/1X PBS, and paraﬃn-embedded and sec-
tioned (6–7mm). Sections were counterstained with Eosin.
For immunohistochemical analysis E14.5 embryos were
ﬁxed overnight in 4% paraformaldehyde/1X PBS, paraf-
ﬁn-embedded and sectioned (6–7mm). Slides were stained
with antibodies against c-myc tag (1/300, 9E10; Abcam)
and GFP (1/300, rabbit IgG fraction; Invitrogen).
Detection was performed with the Envision Kit
(DAKO) according to the manufacturer’s instructions.
Sections were counterstained with hematoxylin. For west-
ern blot analysis ES cells, embryonic and adult tissue sam-
ples were dissolved in standard lysis buﬀer (pH 8.0)
containing phosphatase and protease inhibitors (Com-
plete; Roche Diagnostics), sonicated for 10s and centri-
fuged. Protein concentration was measured with the
BioRad DC kit. Forty micrograms of each sample was
loaded on 8–10% SDS–polyacrylamide gels. Proteins
were transferred onto Immobilon-P membranes (Milli-
pore) and blocked with 5% non-fat dry milk, 0.1%
Tween-20 in Tris-buﬀered saline buﬀer (pH 7.4) prior
to incubation with primary antibody. Antibodies
were obtained from the following companies: b-galactosi-
dase (Molecular Probes, A-11132), E-cadherin (R&D
Systems, MAB 1002), myc (9E10, Abcam), Mdm4
(Sigma, M0445) and Vinculin (Sigma V9131). Detection
was done using horseradish peroxidase-coupled secondary
antibodies (Sigma; 1:10000) and Western Lightning che-
miluminescence reagent (Perkin Elmer).
RESULTS
Conditional ROSA26 targeting vectors compatible with
Gatewaysite-specific recombination cloning
To streamline the production of conditional ROSA26 tar-
geting vectors, we have generated a Gateway ROSA26
destination vector (pROSA26-DV1) as a substrate for
the eﬃcient insertion of cDNAs available as attL1-
cDNA-attL2 entry clones. The Gateway site in the
destination vector is located 30 of a splice acceptor (SA)
followed by a loxP ﬂanked (ﬂoxed) PGK-neo-3xpA
(STOP) cassette (11) and 50 of an IRES-EGFP reporter.
LR reactions yield pROSA26-DV1-derived expres-
sion vectors (top line, Figure. 1). Correct ROSA26
locus targeting was initially screened by Southern blot
analysis of genomic DNA using a 200bp 50 external
probe, previously described for screening ROSA26 recom-
bination events (10). In our hands, this probe gave
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Figure 1. Generation and analysis of Gateway-compatible conditional ROSA26-promoter-based expression alleles. (A) LR reactions performed
between the pROSA26DV-1 vector and cDNA containing pEntry clones for generation of the ROSA26 targeting vector (B). S1 and S2 represent
sequencing primers. Black and blue rectangles are the 50,3 0 external and internal DNA probes. The black double-headed arrows show the expected
5.8-kb (wild-type) and 3.0-kb band sizes (targeted) knock-in (C) alleles in Southern blot analysis using the 50 external probe on BamH1-digested
genomic DNA. Blue arrow shows the expected 4.0-kb band size (targeted) in EcoRV digests using internal neo probe and the red lines depict the
37-kb (wild-type) and 8.8-kb band size (targeted) in KpnI digests using the external 30 probe. (D) Cre-mediated deletion of the intervening loxP
ﬂanked PGK-neo-3xpA (STOP) cassette results in the ROSA26-locus-based expression of an exon1-cDNA-IRES-eGFP bi-cistronic fusion transcript
(SA-splice acceptor). (E) Example of Southern blot conﬁrmation of 3 PCR positive ROSA26-Snai2 based ES cell clones used to conﬁrm
50 integration (left), 30 integration (middle) and single-copy integration (right).
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plate based genomic DNA restriction analysis. High-
throughput screening to identify targeted ES cells was
subsequently used in 96-well plate PCR based screens
designed to ﬁrst identify 50 targeted clones (primers
G1 and G2 in Figure 1b, Supplementary Figure 1).
We subsequently used larger 50 (550bp) and 30 (800bp)
external probes together with an internal neomycin
probe (600bp) to conﬁrm 50 and 30 integration, as well
as single-copy insertion into the ROSA26 locus from
genomic DNA isolated from 24-well plate formats
(Figure 1E). Mice made from ROSA26-targeted ES
cells have been inter-crossed with ubiquitous or tissue/
cell-speciﬁc Cre mice.
The multimerized polyadenylation sequence (3xpA) eﬃ-
ciently stops transcription initiated by both the PGK and
ROSA26 promoters (11), which we conﬁrmed by observ-
ing the lack of EGFP expression prior to Cre-mediated
excision of ﬂoxed PGK-neo-3xpA (STOP) cassette
(Figure 2A). Cre-mediated deletion of the STOP cassette
enables the transcription of the ROSA26 exon1-cDNA-
IRES-eGFP bi-cistronic mRNA (bottom line, Figure 1).
The EGFP reporter marks cells or tissues where the
cDNA of interest is expressed during development and
could facilitate the genotyping of transgenic embryos.
Here we show embryos resulting from crosses between
mice that carry conditional ROSA26-targeted alleles and
three diﬀerent Cre transgenic lines: Sox2-Cre (19) for early
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Figure 2. Generation and analysis of ROSA26-promoter-based mice. (A) Bright ﬁeld (left panel) and ﬂuorescence (eGFP) images (right panel) of
a control non-Cre-excised ROSA26-Snai2-IRES-eGFP
Tg/+ embryo (left) and mutant Sox2-Cre
Tg/+, ROSA26-Snai2-IRES-eGFP
Tg/+ embryo (right)
showing ubiquitous eGFP expression. (B) Merged ﬂuorescence (eGFP) and bright ﬁeld image of Nestin-Cre
Tg/+, ROSA26
Tg/+ embryo showing
eGFP expression in brain and neural tube at E10.5. (C) Fluorescence image of E17.5 forelimb of a Col2-Cre
Tg/+, ROSA26-
Tg/+ embryos showing
eGFP expression in forelimb elements. (D) Image of totally agouti, seemingly 100% G4 ES-cell-derived G0 male mice. (E) Q-RT-PCR analysis
performed on two E11.5 wild-type and 3 Sox2-Cre
Tg/+, ROSA26-Snai2-IRES-eGFP
Tg/+ mutant littermates showing 2-4-fold upregulated Snai2
mRNA expression levels. (F) Wild-type (wt) E14.5 embryo (left) and two mutant (mut) Sox2-Cre
Tg/+, ROSA26-Snai2-IRES-eGFP
Tg/+ littermates
(right) ubiquitously expressing Snai2 showing pallor and cephalic haemorrhage (arrow). (G) Wild-type (wt) control E10.5 embryo compared with two
Sox2-Cre
Tg/+, ROSA26-Snai1-IRES-eGFP
Tg/+ mutant (mut) littermates ubiquitously expressing Snai1 showing severe developmental defects
(left panel).
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Nestin-Cre (20) or Col2-Cre (21) for excision restricted
to the nervous system and to bone/cartilage respectively
(Figure 2B and C).
Through recombination of the pROSA26-DV1 destina-
tion vector with cDNA entry clones, conditional ROSA26
targeting vectors can be created for ES cell electroporation
within 7 to 10 days. To date, we have produced over 20
such vectors carrying diﬀerent classes of genes coding
for growth factors, kinases, transcription factors, extra-
cellular matrix-binding proteins and co-receptors
(Supplementary Table 1). In our hands, the average LR
reaction eﬃciency ranges from 70 to 100% expected
expression vectors recovered in transformed Escherichia
coli colonies (data not shown).
On average, the targeting eﬃciency of the conditional
ROSA26 transgenes in the G4 F1 hybrid ES cells (16) was
around 23% (Supplementary Table 1). In our optimized
pipeline, a cDNA can be transferred from a Gateway
pEntry plasmid to fully characterized single-copy
ROSA26-targeted ES cell clones within 3 to 4 weeks (see
Supplementary Figure 1). Stable conditional transgenic
mice can then be generated from these ES cells with
a very high eﬃciency.
Invivo functionalanalysis ofGateway-compatible
ROSA26 alleles using G4 F1hybrid EScells in
diploid embryo aggregation
We have previously shown that G4 F1 hybrid ES cells
yield mice exclusively derived from ES cells with extreme
eﬃciency via tetraploid embryo complementation assays
(16). We have now extended this approach and demon-
strated that aggregation of Swiss or CD1 morula-stage
diploid embryos with our transgenic G4 ES cells can gen-
erate live oﬀspring in which 60% of the neonates are at
least 30% chimeric as judged by the agouti colour of their
coat, which is a trait of ES cell genetic background.
Furthermore, and most interestingly,  35% of the pups
born were completely agouti implying that these mice were
largely (if not totally) derived from ES cells (Figure2D
and Supplementary Table 1). Furthermore, all completely
agouti males from the 12 ROSA26-targeted ES cell clones
characterized, transmitted the targeted allele with the
expected 50% Mendelian inheritance. Even the lower
30% chimeric oﬀspring all underwent germline transmis-
sion in the ﬁrst litter. Although no formal GPI isozyme
(22) analysis has been performed to conﬁrm the coat-
colour estimation of ES cell contribution of the 100%
agouti colour mice, it is clear that the G4 hybrid ES
cells used in this analysis can out-compete the diploid
host CD1/Swiss embryos in giving rise to adult tissues
and most importantly to the germline of these founder
males.
The initial analysis using our transgenic system focused
on two Snai gene family members (Snai1 or Snail, and
Snai2 or Slug). Snai genes code for transcriptional repres-
sors involved in the epithelial mesenchymal transition
(EMT) that takes place during tissue morphogenesis and
have been implicated in cancer progression (23,24).
Quantitative RT-PCR analysis of Cre-excised ES cell
clones showed 2–4-fold increases in Snai2 and Snai1
mRNA compared to endogenous levels (data not shown,
Figure 4E). Such increases were also observed in
Sox2-Cre
Tg/+, ROSA26
Tg/+ double transgenic embryos
expressing Snai2 ubiquitously conﬁrmed by ﬂuorescence
microscopy for eGFP (right panel, Figure 2A and E).
Ubiquitous expression of Snai2at these modest levels
resulted in variable embryonic lethality, with most
embryos showing paleness and cephalic haemorrhaging
around embryonic day (E) 13.5–15.5 (Figure 2F). On the
other hand, similar levels of ubiquitous Snai1 expression
resulted in 100% lethality around E10.5 due to severe
global developmental malformations (Figure 2G).
We are presently analysing the causes of embryonic
lethality caused by ubiquitous Snai1/2 expression.
Similar moderate expression has also been documented
with several other genes including various VEGF
isoforms, as well as Mdm4 Cre-excised ROSA26-locus-
targeted ES cells (Figure 5a, data not shown).
Conditional ROSA26 targeting vectors forhigher
transgene expression compatible with MultiSite
Gateway cloning
ROSA26-promoter-based expression is relatively moder-
ate (see above). In order to obtain higher levels of trans-
gene expression, we designed two MultiSite Gateway
destination vectors for the insertion of the strong
CAGG promoter (25) ﬂoxed bgeo-STOP cassette into
the ROSA26 locus, either in sense (pROSA26-DV3) or
anti-sense orientations (pROSA26-DV2) (Figure 3). The
later conﬁguration was included because the minimal cmv
promoter was previously shown to yield higher levels of
expression when inserted in the anti-sense versus sense
orientation relative to the ROSA26 sense promoter (26).
In our MultiSite system, the CAGG promoter ﬂoxed
bgeo-STOP cassette, the cDNA of interest and the
IRES-eGFP reporter cassette are in the 50, middle and 30
position, respectively. In both orientations, the bgeo cas-
sette was transcribed before Cre-mediated excision under
the control of the CAGG promoter. In cells with the non-
excised locus, lacZ in situ staining, b-galactosidase mRNA
and protein levels were widespread and signiﬁcantly
higher in the anti-sense conﬁguration (Figure 4a–c).
Following Cre-mediated excision of the ﬂoxed bgeo-
STOP cassette, undiﬀerentiated ES cell colonies in which
Snai1 expression was under the control of the CAGG pro-
moter already showed morphological changes (Figure 4d),
a result that is consistent with the ability of Snai1 to
negatively regulate key adhesion molecules such as
E-cadherin (27,28). We next compared mRNA expression
driven by the CAGG or the ROSA26 promoter following
Cre-mediated excision in ES cells carrying the Snai1
cDNA transgene. The pCAGG-promoter-driven expres-
sion was 8–10-fold higher than ROSA26-promoter-based
expression (Figure 4E). Enhanced Snai1 expression and
altered ES cell morphology was indeed associated with
decreased E-Cadherin protein levels that is one of the
major epithelial targets repressed by the Snai1 protein
(29) (Figure 4F) and these cells were morphologically
very similar to E-cadherin deﬁcient ES cell cultures (30).
e55 Nucleic Acids Research,2009, Vol. 37,No. 7 PAGE6 OF12Next, we determined whether the ROSA26 locus con-
taining the CAGG promoter in the anti-sense orientation
could also drive widespread and enhanced transgene
expression of Mdm4 in ES cells as well as in adult mice.
Similar to the Snai1 expression results, Cre-excised
CAGG-promoter-based expression of Mdm4 in the anti-
sense orientation was around 10 times higher than
ROSA26-promoter-driven expression compared with
non-excised parental ES cells (Figure 5A).
Completely agouti males derived from ES cells carrying
the conditional ROSA26-pCAGG-Mdm4 allele were
inter-crossed either with B6 females to establish the
conditional ROSA26-pCAGG-Mdm4line on a pure B6
background or Sox2-Cre females. Oﬀspring from the
later inter-crosses were either analysed at E14.5 for expres-
sion of the myc-tagged Mdm4 protein in immunohisto-
chemistry (IHC) analysis or were allowed to develop to
term. Double transgenic mice were born in Mendelian
numbers and showed no overt phenotypes. This result
was somewhat expected, given the predominant role of
Mdm4 in p53 regulation and the Mendelian birth ratios
of p53 null embryos (31).
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from Sox-2 Cre
Tg/+, ROSA26-pCAGG-myc-Mdm4
Tg/+
inter-crosses revealed widespread expression of the myc-
tagged Mdm4 protein, while no myc-tagged Mdm4 pro-
tein was detected on control sections from Cre negative,
ROSA26-pCAGG-myc-Mdm4
Tg/+ embryos (Figure 5B
and Supplementary Figure 2). Closer inspection of the
various embryonic tissues showed widespread myc-
tagged Mdm4 protein expression localized to the cyto-
plasm and nucleus in many tissues including the central
nervous system and skeletal muscle whereas a smaller
subset of tissues showed more mosaic expression of
the myc-tagged Mdm4 protein including the lung, liver
and especially chondrogenic tissues (Figure 5B and data
not shown). A similar expression proﬁle was observed
for EGFP in IHC analysis (Supplementary Figure 2E
and F). X-gal staining of non-Cre excised ROSA26-
pCAGG-myc-Mdm4
Tg/+ embryos showed more mosaic
b-galactosidase expression (Supplementary Figure 3) that
did not completely overlap with the myc-Mdm4 and
EGFP IHC analysis (Supplementary Figure 2). In order
to investigate the ubiquity of Sox2-Cre-mediated deletion
of the ﬂoxed b-geo-3XpA+ stop cassette we next per-
formed genomic PCR analysis from adult tissues from
Sox-2 Cre
Tg/+, ROSA26-pCAGG-myc-Mdm4
Tg/+ mice
along with non-excised controls. Genomic PCR analysis
with speciﬁc primer pairs showed that Sox2-Cre expres-
sion resulted in the complete deletion of the b-geo-STOP
cassette in a wide range of adult tissues (Figure 5C). Q-
RT-PCR analysis performed on the same tissue samples
showed expression of Mdm4 and eGFP mRNA tran-
scripts (Figure 5D). Furthermore, western blot analysis
using anti-myc-tag or Mdm4-speciﬁc antibodies showed
myc-tagged Mdm4 protein expression in the same adult
tissues (Figure 5E and data not shown). Similar to the
developmental analysis, X-gal staining of adult tissue
sections showed mosaic b-galactosidase expression
(Supplementary Figure 4) that did not completely cor-
respond with the post-excision expression results
(Figure 5D and E).
DISCUSSION
The goal of this study was to improve gain-of-
function transgenic strategies by targeting cDNAs to a
well-deﬁned locus and introducing very eﬃcient in vitro
cloning in combination with more broadly applicable
ES-cell-based technologies. Here, we have used the
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duce various cDNAs and demonstrate that we could
obtain with high targeting eﬃciency single-copy trans-
genes conditionally expressed from the endogenous
ROSA26 promoter.
The ability of the G4 ES-cell-derived founder males
to eﬃciently transmit the conditional ROSA26-based
transgene in the ﬁrst litter is further expected to decrease
the waiting time and number of chimeras that have to
be analysed for germline transgene transmission. Such
mice can be immediately bred to any Cre line of interest
to obtain transgenic animals with modest ROSA26-
promoter-driven transgenic expression according to the
wide spectrum of constitutive and inducible tissue-speciﬁc
Cre lines currently available (see http://www.mshri.on.ca/
nagy for a partial and ever-expanding list).
An additional beneﬁt of using the Gateway recombina-
tion system in tandem with our ROSA26 locus targeting
vectors is that there is an ever-growing list of Gateway-
compatible pEntry clones (32) as well as commercially and
publicly available attB-containing cDNA vectors that
can be converted into pEntry clones by performing BP
reactions with donor vectors containing the corresponding
attP sites (as an example see the following web
resource: http://www.imagenes-bio.de/products/sets_
libraries/image). These vectors and approaches outlined
in this manuscript therefore set the stage for the high-
throughput systemized creation of conditional gain-
of-function ES cell libraries carrying a wide spectrum of
ORF subfamilies. To further increase targeting eﬃciencies
that would be needed for the eﬃcient creation of such
gain-of-function resources, the Gateway technologies
described here should in the future be merged with
in vivo recombinase-based technologies such as [FlpE/Frt
(33), and uC31/attP systems (34)] to enable recombinase-
mediated cassette exchange (RMCE) in vivo to the
ROSA26 locus (35,36) as well as other loci (37).
These types of RMCE-based, ROSA26-based-targeting
approaches have already been demonstrated to be extre-
mely eﬃcient in the creation of RNA polymerase III-
based gene knockdowns using gene-speciﬁc shRNA
sequences (35,38).
Using MultiSite Gateway recombination technologies
we have inserted the strong CAGG promoter bi-direction-
ally into the ROSA26 locus in both a sense and anti-sense
orientation relative to the ROSA26 sense promoter. We
have demonstrated that in undiﬀerentiated ES cells, the
anti-sense conﬁguration of the pCAGG promoter is opti-
mal for enhanced expression compared to the sense orien-
tation. This result is consistent with previous reports that
the minimal cytomegalovirus (CMV) promoter elements
also drive higher transgene expression in the anti-sense
orientation in undiﬀerentiated ES cells, a result that is
thought to be due to ROSA26 sense promoter interference
(26). In our initial analysis of the ROSA26-pCAGG-myc-
Mdm4 mice we can clearly see widespread Mdm4 and
eGFP protein expression during development (at E14.5)
and widespread expression in the adult in Cre-excised
tissues. However, we have also documented that there
is a signiﬁcant lack of correlation between pCAGG pro-
moter-driven b-galactosidase expression and X-gal
staining in the non-excised situation compared with the
broader expression of myc-Mdm4 transgene following
Cre-mediated excision of the ﬂoxed bgeo STOP cassette.
In addition, our initial analysis of Mdm4 protein expres-
sion demonstrates that even after Cre-mediated excision of
the b-geo STOP cassette we are not getting truly ubiqui-
tous protein expression. For our purposes where we want
to mimic the tumour situation in which there is clonal
expansion of a small subset of transformed cells, mosaic
but high levels of Mdm4 expression may be acceptable or
even desirable. However, for studies where ubiquitous
expression of the transgene is essential in a given tissue,
we propose that the ROSA26-promoter-based expression
strategies outlined above are superior when used with
well-characterized Cre lines.
Previous attempts to use the CAGG promoter in the
generation of the Cre-based bi-reporter Z/AP (39) and
Z/EG (18) mice have demonstrated similar ﬁndings to
those which we have documented in this study. Random
integration of the pCAGGs-based vectors into undiﬀeren-
tiated ES cells resulted in only around 10% of single-copy
random integrants that showed ubiquitous (>90%) X-gal
staining in undiﬀerentiated ES cell clones. These results
indicate that the CAGGs promoter is quite sensitive to
positional integration eﬀects and raise the possibility of
promoter interference from the ROSA26 anti-sense-pro-
moter in a tissue-speciﬁc manner (40). As well, the lack of
correlation between pre-Cre excision-based expression of
b-galactosidase and post-Cre-based expression of reporter
constructs (18,39) is similar to our observed results where
b-galactosidase expression showed more limited and
mosaic expression compared with Cre-mediated expres-
sion of myc-Mdm4 protein and EGFP. These results
may be attributable to elements within the b-geo cassette
interfering with pCAGGs-based expression prior to Cre-
excision and/or the fact that the bacterial b-galactosidase
gene has previously been demonstrated to show mosaic
expression particularly in adult tissues (41,42) that may
be related to sub-optimal codon usage of the prokaryote
sequences (18) or transgene silencing (41,42).
These studies demonstrate that caution should be taken
when inserting exogenous promoters into the ROSA26
locus in both sense and anti-sense orientations and it is
still not clear if tissue-speciﬁc promoter elements can be
used to drive ubiquitous and/or cell/tissue-speciﬁc expres-
sion from this locus on their own during development and
in the adult. Recently, several groups have demonstrated
the utility of using insulator sequences in transgenic stu-
dies (43). Ciavatta et al. (44) have demonstrated that copy
number-dependent use of insulator sequences at the
widely expressed HPRT locus can dramatically protect
chicken-b-actin-promoter-based EGFP expression during
development and in adult tissues. It is envisioned that
similar strategies should in the future be used for the tar-
geting of the pCAGG or other tissue-speciﬁc promoters to
the ubiquitously expressed ROSA26 locus.
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